Development of a New Risk Score for Hospital-associated Venous Thromboembolism in Noncritically Ill Children: Findings from a Large Single-institutional Case-control Study
Overview
Authors
Affiliations
Objective: To determine risk factors for pediatric hospital-associated venous thromboembolism (HA-VTE) in noncritically ill children to derive a novel HA-VTE risk model for this population.
Study Design: Patients with HA-VTE were identified retrospectively via the electronic health record at All Children's Hospital Johns Hopkins Medicine from April 10, 2013 through January 1, 2006. Seven contemporaneous, noncritically ill control children were randomly selected for each case of HA-VTE. The association between putative risk factors and HA-VTE was estimated with ORs and 95% CIs, which were calculated using the Wald method. A P-value threshold ≤.2 was used in univariate analysis for inclusion into a multivariate (adjusted) model.
Results: Fifty cases of HA-VTE occurred in noncritically ill children. The presence of a central venous catheter (OR 27.67, 95% CI, 8.40-91.22), infection (OR 10.40, 95% CI, 3.46-31.25), and length of stay ≥4 days (OR 5.26, 95% CI, 1.74-15.88) were found to be statistically significant risk factors for HA-VTE. An 8-point risk score was derived in which scores of 8 points, 7 points, and ≤6 points corresponded to venous thromboembolism risks of 12.5%, 1.1%, and 0.1%, respectively.
Conclusion: The presence of a central venous catheter, infection, and length of stay ≥4 days are significant risk factors for HA-VTE in noncritically ill children, forming the basis for a new risk score that could inform venous thromboembolism prophylaxis decision-making. These findings warrant prospective validation.
Walker S, French B, Moore R, Domenico H, Wanderer J, Mixon A JAMA Netw Open. 2023; 6(10):e2337789.
PMID: 37831448 PMC: 10576217. DOI: 10.1001/jamanetworkopen.2023.37789.
Tian L, Su Y, Gao H, Wang L, Zeng J, Yang Q Eur J Pediatr. 2023; 182(11):4909-4919.
PMID: 37606700 DOI: 10.1007/s00431-023-05078-x.
Walker S, French B, Moore R, Domenico H, Wanderer J, Balla S Trials. 2022; 23(1):901.
PMID: 36273203 PMC: 9588222. DOI: 10.1186/s13063-022-06823-7.
Stephens E, Nguyen A, Jaffray J, Branchford B, Amankwah E, Goldenberg N Res Pract Thromb Haemost. 2022; 6(7):e12810.
PMID: 36254253 PMC: 9561357. DOI: 10.1002/rth2.12810.
A Real-time Risk-Prediction Model for Pediatric Venous Thromboembolic Events.
Walker S, Creech C, Domenico H, French B, Byrne D, Wheeler A Pediatrics. 2021; 147(6).
PMID: 34011634 PMC: 8168609. DOI: 10.1542/peds.2020-042325.